Craig-Hallum Maintains Buy on GeneDx Hldgs, Raises Price Target to $95
Portfolio Pulse from Benzinga Newsdesk
Craig-Hallum analyst Bill Bonello has maintained a Buy rating on GeneDx Holdings (NASDAQ:WGS) and raised the price target from $70 to $95.
October 30, 2024 | 1:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Craig-Hallum analyst Bill Bonello has maintained a Buy rating on GeneDx Holdings and increased the price target from $70 to $95, indicating a positive outlook.
The analyst's decision to maintain a Buy rating and raise the price target suggests confidence in GeneDx's future performance, likely leading to positive investor sentiment and potential stock price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100